Label: REFRESH TEARS PF- carboxymethylcellulose sodium, glycerin solution/ drops
- NDC Code(s): 0023-3110-10, 0023-3110-35, 0023-3110-50
- Packager: Allergan, Inc.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated March 1, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active ingredients
- Purpose
- Uses
-
Warnings
-
For external use only.
-
To avoid contamination, do not touch tip of container to any surface. Replace cap after using.
- If solution changes color, do not use.
-
For external use only.
- Directions
- Other information
- Inactive ingredients
- Questions or comments?
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
REFRESH TEARS PF
carboxymethylcellulose sodium, glycerin solution/ dropsProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:0023-3110 Route of Administration OPHTHALMIC Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CARBOXYMETHYLCELLULOSE SODIUM (UNII: K679OBS311) (CARBOXYMETHYLCELLULOSE - UNII:05JZI7B19X) CARBOXYMETHYLCELLULOSE SODIUM 5 mg in 1 mL GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) GLYCERIN 9 mg in 1 mL Inactive Ingredients Ingredient Name Strength BORIC ACID (UNII: R57ZHV85D4) CALCIUM CHLORIDE (UNII: M4I0D6VV5M) ERYTHRITOL (UNII: RA96B954X6) LEVOCARNITINE (UNII: 0G389FZZ9M) MAGNESIUM CHLORIDE (UNII: 02F3473H9O) POTASSIUM CHLORIDE (UNII: 660YQ98I10) WATER (UNII: 059QF0KO0R) SODIUM BORATE (UNII: 91MBZ8H3QO) TRISODIUM CITRATE DIHYDRATE (UNII: B22547B95K) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:0023-3110-10 1 in 1 CARTON 03/01/2024 1 10 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product 2 NDC:0023-3110-35 1 in 1 CARTON 03/01/2024 2 10 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product 3 NDC:0023-3110-50 1 in 1 CARTON 03/01/2024 3 3.5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M018 03/01/2024 Labeler - Allergan, Inc. (144796497)